← Back to headlines
Embecta Stock Target Cut as Medtech Sentiment Weakens
Embecta (EMBC) has experienced a significant target cut from analysts, attributed to a weakening sentiment in the medtech sector.
24 May, 11:48 — 24 May, 11:48
Sources
Showing 1 of 1 sources
